Michael Berry had positive comments about PLC a few days ago on The Life Sciences Report. He called it a classic discovery play. He was not paid and has no financial relationship with PLC per the disclaimers.
Michael Berry's comments from the Life Sciences Report were a strong long term endorsement on retiring boomers.
MB: Yes. I have one name that is classic discovery play— PLC Medical Systems Inc. (PLCSF:OTCQB).
The company's therapy addresses the aging boomer generation and a problem that current dialysis procedures tend to cause, contrast-induced nephropathy (CIN). Dialysis procedures will explode in the next decade, as the world's population ages and Type 2 diabetes takes a grim hold on seniors. CIN will explode too, and with it the need for less toxic examination procedures. CIN impairs renal function and is one of the leading causes of renal failure, and 10–20% of dialysis patients are impacted by CIN—a huge proportion.
PLC's RenalGuard is a therapy that reduces toxicity in the kidney by removing the toxic contrast dyes used in dialysis procedures. It is commercialized in Europe now, and European patients have experienced a 70% lower incidence of CIN problems.
We estimate this market to be worth $500M today, and it is sure to grow. There are more interesting applications here as well. This is one company to keep an eye on.
TLSR: Thanks for your time, Mike.
MB: My pleasure, George.
Michael Berry will be speaking at the upcoming the Mines and Money Australia 2013 convention in Melbourne Australia, as well as at the Australia Biotech Invest 2013 conference.
From 1982–1990, Michael Berry served as a professor of investments at the Colgate Darden Graduate School of Business Administration at the University of Virginia, during which time he published a book, Managing Investments: A Case Approach. He was the Wheat First Professor of Investments at James Madison University. He has managed small- and mid-cap value portfolios for Heartland Advisors and Kemper Scudder. His publication, Morning Notes, analyzes emerging geopolitical, technological and economic trends. He travels the world with his son, Chris, looking for discovery opportunities for his readers.